E1	Condition:T1 Name:T2 Temporality:E7
E4	Age:T14 Numeric-Filter:E3
E5	Eq-Comparison:T20 Operator:T9 Temporal-Unit:T13 Value:T19
E6	Eq-Comparison:T21 Temporal-Period:T22
E7	Eq-Comparison:T23 Operator:T24 Value:T17 Temporal-Unit:T11
E3	Eq-Comparison:T4 Operator:T7 Temporal-Unit:T10 Value:T15
E11	Study:T29 
E12	Observation:T30 Name:T31
E13	Observation:T32 Name:T33 Temporality:E14
E14	Eq-Comparison:T34 Operator:T8 Temporal-Unit:T12 Value:T18
E15	Eq-Comparison:T26 Temporal-Recency:T35
E16	Procedure:T36 Temporality:E15
E17	Drug:T37 Name:T38
E18	Study:T39 Temporality:E6
E19	Condition:T40 Name:T41
E20	Condition:T42 Name:T43
E22	Procedure:T45 Temporality:E5
E23	Drug:T46 
E24	Study:T47 Study-Of:E23
E25	Study:T28 
E26	Drug:T48 Name:T49
E27	Condition:T50 Name:T51
E28	Modifier:T52 Modifies:T2
T1	Condition 567 575	diabetes
T2	Condition-Name 567 575	diabetes
T5	Life-Stage-And-Gender 454 460	female
T6	Life-Stage-And-Gender 446 450	Male
T7	Eq-Operator 466 487	greater than or equal
T8	Eq-Operator 673 691	less than or equal
T9	Eq-Operator 1037 1043	within
T10	Eq-Temporal-Unit 494 499	years
T11	Eq-Temporal-Unit 588 593	weeks
T12	Eq-Temporal-Unit 698 703	weeks
T13	Eq-Temporal-Unit 1047 1051	days
T14	Age 462 465	age
T15	Eq-Value 491 493	18
T17	Eq-Value 585 587	12
T18	Eq-Value 695 697	12
T19	Eq-Value 1044 1046	90
T20	Eq-Comparison 1037 1051	within 90 days
T21	Eq-Comparison 774 782	Previous
T22	Eq-Temporal-Period 774 782	Previous
T23	Eq-Comparison 576 593	at least 12 weeks
T4	Eq-Comparison 466 499	greater than or equal to 18 years
T24	Eq-Operator 576 584	at least
T29	Study 603 612	inclusion
T30	Observation 643 658	haemoglobin A1c
T31	Observation-Name 643 658	haemoglobin A1c
T32	Observation 660 665	HbA1c
T33	Observation-Name 660 665	HbA1c
T34	Eq-Comparison 673 703	less than or equal to 12 weeks
T26	Eq-Comparison 713 723	initiation
T35	Eq-Temporal-Recency 713 723	initiation
T36	Procedure 739 748	treatment
T37	Drug 727 738	semaglutide
T38	Drug-Name 727 738	semaglutide
T39	Study 805 810	study
T40	Condition 889 906	Mental incapacity
T41	Condition-Name 889 906	Mental incapacity
T42	Condition 925 942	language barriers
T43	Condition-Name 925 942	language barriers
T45	Procedure 997 1006	Treatment
T46	Drug 1032 1036	drug
T47	Study 1016 1031	investigational
T28	Study 1080 1085	study
T48	Drug 1111 1122	semaglutide
T49	Drug-Name 1111 1122	semaglutide
T50	Condition 1091 1107	Hypersensitivity
T51	Condition-Name 1091 1107	Hypersensitivity
T52	Modifier 560 566	type 2
A1	Life-Stage-And-Gender-Type T5 female
A2	Life-Stage-And-Gender-Type T6 male
A3	Eq-Operator-Value T7 GTEQ
A4	Eq-Operator-Value T8 LTEQ
A5	Eq-Operator-Value T9 LTEQ
A6	Eq-Temporal-Unit-Value T10 year
A7	Eq-Temporal-Unit-Value T11 week
A8	Eq-Temporal-Unit-Value T12 week
A9	Eq-Temporal-Unit-Value T13 day
A10	Eq-Temporal-Period-Value T22 past
A14	Eq-Operator-Value T24 GTEQ
A15	Observation-Type-Value E12 lab
A16	Observation-Type-Value E13 lab
A12	Eq-Temporal-Recency-Value T35 first-time
R1	Abbrev-Of Arg1:E13 Arg2:E12
R2	Using Arg1:E16 Arg2:E17
R3	Using Arg1:E22 Arg2:E23
R4	Caused-By Arg1:E27 Arg2:E26
R5	Before Arg1:E14 Arg2:E15
R6	Before Arg1:E5 Arg2:E25
R7	Or Arg1:T6 Arg2:T5
R8	Before Arg1:E7 Arg2:E11
R9	Or Arg1:E19 Arg2:E20
